Moderna (MRNA) Prepaid Assets (2017 - 2026)

Moderna (MRNA) has 10 years of Prepaid Assets data on file, last reported at $348.0 million in Q1 2026.

• Prepaid Assets for Q1 2026 came in at $348.0 million, down 40.51% year-over-year; the trailing twelve-month figure through Mar 2026 was $348.0 million (down 40.51% YoY), and the FY2025 annual result was $45.0 million, down 92.49% from the prior year.
• Prepaid Assets grew to $348.0 million in Q1 2026 per MRNA's latest filing, from $45.0 million in the prior quarter.
• Over five years, Prepaid Assets peaked at $1.2 billion in Q2 2023 and troughed at $44.0 million in Q4 2022.
• A 5-year average of $622.4 million and a median of $627.0 million in 2023 frame the typical range for Prepaid Assets.
• The sharpest annual moves came in 2022 and 2023: Prepaid Assets jumped 2673.68% in 2022, then tumbled 94.29% in 2023.
• A 5-year view of Prepaid Assets shows it stood at $44.0 million in 2022, then surged by 1325.0% to $627.0 million in 2023, then decreased by 4.47% to $599.0 million in 2024, then plunged by 92.49% to $45.0 million in 2025, then surged by 673.33% to $348.0 million in 2026.
• Business Quant data shows MRNA's Prepaid Assets at $348.0 million in Q1 2026, $45.0 million in Q4 2025, and $716.0 million in Q3 2025.